Mirvaso
Galderma
Description
Brimonidine is a highly selective alpha2-adrenergic receptor agonist that is 1000-fold more selective for the alpha2-adrenergic receptor than the alpha1-adrenergic receptor. Cutaneous facial application of a highly selective alpha2-adrenergic receptor agonist reduces erythema through direct cutaneous vasoconstriction.
Indications
For the symptomatic treatment of facial erythema of rosacea in adult patients.
Price
30g, £33.69
More on: Rosacea treatments